Cyclic lipopeptides as antibacterial agents - potent antibiotic activity mediated by intriguing mode of actions.
about
Recent contributions of structure-based drug design to the development of antibacterial compounds.Separation of cyclic lipopeptide puwainaphycins from cyanobacteria by countercurrent chromatography combined with polymeric resins and HPLC.Therapeutic cyclic lipopeptides mining from microbes: latest strides and hurdles.Heterophyllin B inhibits the adhesion and invasion of ECA-109 human esophageal carcinoma cells by targeting PI3K/AKT/β-catenin signaling.Anaerobes as Sources of Bioactive Compounds and Health Promoting Tools.Structure-activity relationships in ultrashort cationic lipopeptides: the effects of amino acid ring constraint on antibacterial activity.Targeting a cell wall biosynthesis hot spot.Recent advances in synthetic lipopeptides as anti-microbial agents: designs and synthetic approaches.Rapid Turbidimetric Assay to Determine the Potency of Daptomycin in Lyophilized Powder.In Silico Discovery of Novel Ligands for Antimicrobial Lipopeptides for Computer-Aided Drug Design.A High-Resolution Crystal Structure that Reveals Molecular Details of Target Recognition by the Calcium-Dependent Lipopeptide Antibiotic Laspartomycin C.Impact of a stereocentre inversion in cyclic lipodepsipeptides from the viscosin group: a comparative study of the viscosinamide and pseudodesmin conformation and self-assembly.First total synthesis of WLIP: on the importance of correct protecting group choice.Synergistic activity of cosecreted natural products from amoebae-associated bacteria.Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents
P2860
Q30380194-5AE1B332-8E2F-4C35-A4FF-AB466E99804BQ31146261-E5F36101-EA2B-4649-AB40-2C08BC37E417Q38515064-8BAA39D4-432D-43D3-8864-CF5C03228BA3Q38813473-C5523F49-8C94-4F61-9861-D26C07F5C89CQ38901723-40A7F9A4-2D8F-4CA5-B8A4-4AACE224B28FQ38970950-3D8C3D34-B513-4A1B-A8FB-1DDBD12607E2Q39413308-AC4D71FA-C730-4B68-A211-9B85B1508F9EQ40087009-76D3F44A-05B5-4E13-B57F-53C26E8A6706Q41610683-1B54A957-9BD8-4B1C-AC1D-4E0993CB8E45Q47316754-80B55862-465A-4709-9C85-FDD9E046D21BQ48357741-4AB7D422-049F-41B0-9CB9-B51D14EDCBADQ49037430-5CC7ABE8-AF9A-4AD1-91E2-3F07D809A657Q49074495-31403F6B-FC0B-4F18-8DC2-875E1FD4E129Q51144180-C4B49D6C-FF3D-469B-9E0D-25BFD2194F2BQ58582789-01EDDCAF-3F08-4D42-855D-F0C054015CA8
P2860
Cyclic lipopeptides as antibacterial agents - potent antibiotic activity mediated by intriguing mode of actions.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cyclic lipopeptides as antibac ...... by intriguing mode of actions.
@en
type
label
Cyclic lipopeptides as antibac ...... by intriguing mode of actions.
@en
prefLabel
Cyclic lipopeptides as antibac ...... by intriguing mode of actions.
@en
P2093
P1476
Cyclic lipopeptides as antibac ...... by intriguing mode of actions.
@en
P2093
Anna Müller
Harald Gross
Henrike Miess
P356
10.1016/J.IJMM.2013.08.009
P577
2013-09-04T00:00:00Z